Eagle Pharmaceuticals
EGRX
#10486
Rank
S$4.18 M
Marketcap
S$0.32
Share price
0.00%
Change (1 day)
-70.59%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: S$4.18 Million

As of February 2026 Eagle Pharmaceuticals has a market cap of S$4.18 Million. This makes Eagle Pharmaceuticals the world's 10486th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026S$4.18 M-44.07%
2025S$7.48 M-22.72%
2024S$9.68 M-89.2%
2023S$89.7 M-82.41%
2022S$0.51 B-42.63%
2021S$0.88 B10.74%
2020S$0.80 B-27.29%
2019S$1.10 B44.16%
2018S$0.76 B-28.17%
2017S$1.06 B-40.01%
2016S$1.77 B-9.39%
2015S$1.96 B582.2%
2014S$0.28 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
S$4.12 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$729.62 B 17,424,761.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$376.27 B 8,986,068.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
S$1.174 T 28,053,046.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$252.37 B 6,027,171.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$151.39 B 3,615,426.51%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$152.59 B 3,644,147.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$51.98 B 1,241,408.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel